 |
 |

Memory Evaluation in Alzheimer's DiseaseCaregivers' Appraisals and Objective Testing
Elisabeth Koss, PhD;
Marian B. Patterson, PhD;
Ray Ownby, MD, PhD;
Jon C. Stuckey, PhD;
Peter J. Whitehouse, MD, PhD
Arch Neurol. 1993;50(1):92-97.
Abstract
 |  |
Objectives. —To evaluate if caregivers are reliable informants concerning memory deficits in patients with Alzheimer's disease (AD).
Design. —Responses of caregivers of patients with probable AD and responses of healthy control subjects on a standardized memory questionnaire were compared with objective measures of cognition (Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery) and with clinical estimates of activities of daily living, depression, and psychopathology (Consortium to Establish a Registry for Alzheimer's Disease [CERAD] clinical assessment battery) using the Self-report Memory Questionnaire.
Setting. —A federally funded AD research center.
Subjects. —The referred sample included 117 patients with probable AD, their informants, and 41 healthy control subjects age-matched to the patients. Patients and control subjects were between the ages of 58 and 85 years, had between 9 and 19 years of education, and were in good health.
Exclusions. —Patients who did not meet NINCDS-ADRDA criteria of probable AD.
Main Outcome Measure. —The optimal number of questionnaire items yielding the best combination of sensitivity and specificity.
Results. —An abbreviated version of the scale, renamed the Short-Memory Questionnaire, had excellent specificity and sensitivity for identifying dementia. Positive and negative predictive values were 63.5% and near 100%, respectively. The Short-Memory Questionnaire showed good reliability, internal consistency, and external validity. Caregiver appraisals of memory deficits significantly correlated with objective measures of memory and also with generalized cognitive dysfunction.
Conclusions. —Caregivers of patients with AD are reliable informants of their relatives' deficits. The Short-Memory Questionnaire is an easily administered, informant-based scale that may be useful in clinical settings or epidemiologic studies to screen out persons with memory difficulties.
Author Affiliations
From the Departments of Neurology, Case Western Reserve University and University Hospitals of Cleveland (Ohio) (Drs Koss, Patterson, Whitehouse, and Stuckey) and the North Eastern Ohio Universities, College of Medicine (Dr Ownby). Dr Ownby is now with the University of Miami (Fla) School of Medicine, Department of Psychiatry.
Footnotes
Accepted for publication August 14, 1992.
Reprint requests to Department of Neurology, Case Western Reserve University/University Hospitals of Cleveland Alzheimer Center, 2074 Abington Rd, Cleveland, OH 44106 (Dr Koss).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Integrating Patient and Informant Reports on the Cornell-Brown Quality-of-Life Scale
Ready and Ott
AM J ALZHEIMERS DIS OTHER DEMEN 2008;22:528-534.
ABSTRACT
A review of screening tests for cognitive impairment
Cullen et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:790-799.
ABSTRACT
| FULL TEXT
Knowledge of personal information and caregiver awareness in Alzheimer's disease
Ala et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:119-125.
ABSTRACT
Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study
Ikeda et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:146-148.
ABSTRACT
| FULL TEXT
Diagnostic Evaluation of Elderly Patients with Mild Memory Problems
Karlawish and Clark
ANN INTERN MED 2003;138:411-419.
ABSTRACT
| FULL TEXT
Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire
Benedict et al.
Mult Scler 2003;9:95-101.
ABSTRACT
Epistemological Issues in the Study of Insight in People with Alzheimer's Disease
Sabat
Dementia 2002;1:279-293.
ABSTRACT
Increased prevalence of vascular dementia in Japan: A community-based epidemiological study
Ikeda et al.
Neurology 2001;57:839-844.
ABSTRACT
| FULL TEXT
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris et al.
Arch Neurol 2001;58:397-405.
ABSTRACT
| FULL TEXT
North of England evidence based guidelines development project: guideline for the primary care management of dementia
Eccles et al.
BMJ 1998;317:802-808.
FULL TEXT
The Prediction of Alzheimer Disease: The Role of Patient and Informant Perceptions of Cognitive Deficits
Tierney et al.
Arch Neurol 1996;53:423-427.
ABSTRACT
|